Pharmaceutical preparations for gene therapy and gene modulation; pharmaceutical compositions and therapeutic products in the nature of chemical and biological small molecules to degrade RNA, enhance expression, induce exon skipping, and rescue genetic lesions; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; Medical diagnostic apparatus for testing and sequencing DNA and RNA in the fields of genetics, genomics, gene modulation and genetic engineering; medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics and gene modulation; Testing, inspection, research, and development of pharmaceutical preparations for gene modulation; Development of pharmaceutical preparations for use in gene modulation; laboratory research in the fields of genetics, gene modulation, drug development; Genomic analysis and sequencing services for medical purposes; DNA and RNA analysis and sequencing services for medical purposes